Skip to main content

Main navigation (Don Not Delete)

Menu

Products

Login

What are you looking for?

ID for top search

All Filters

Therapeutic Area

Therapeutic Area

Anti-infective

Cardiology

Oncology

Dermatology

Immunology

Date Published

Date published

Any Time

In the last month

In the last six months

In the last year

ID

Print
PDF

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

Asset 12.png

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

Asset 13.png

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

Asset 15.png

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Image

DUB_NOV_UAE_corp_26011_KESIMPTA_

Print
PDF

Novartis UAE

This site is intended for Healthcare Professionals only.
Adverse Event Reporting
For Adverse event reporting to UAE EDE, please contact:
Email: [email protected]
website : Services | Ministry of Health and Prevention - United Arab Emirates
For any adverse events in Abu Dhabi, please report it to
Pharmacovigilance & Drugs Education [email protected]

To Report adverse events to Novartis: Email to [email protected]
or Report online by visiting https://www.report.novartis.com/
©2025 Novartis Middle East FZE

Helpful links

Terms of Use

Privacy Policy

Website Privacy Policy

Site Map

© 2026 Novartis